City snapshot: GSK exits Haleon with £1.25bn share sale

Haleon Sensodyne

Pharma giant GSK has exited its investment in its former healthcare arm Haleon after selling off its final stake in the demerged business

 

Already have an account? Sign in here

You’ve used up your article allowance

Sign up to read more stories for free

Register now